Additional file 6: of A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Authors :: Zhao, Wan-Hong
Liu, Jie
Bai-Yan Wang
Yin-Xia Chen
Cao, Xing-Mei
Yang, Yun
Zhang, Yi-Lin
Fang-Xia Wang
Zhang, Peng-Yu
Lei, Bo
Gu, Liu-Fang
Wang, Jian-Li
Yang, Nan
Zhang, Ru
Zhang, Hui
Shen, Ying
Bai, Ju
Xu, Yan
Xu-Geng Wang
Zhang, Rui-Li
Wei, Li-Li
Zong-Fang Li
Li, Zhen-Zhen
Geng, Yan
He, Qian
Qiu-Chuan Zhuang
Fan, Xiao-Hu
He, Ai-Li
Wang-Gang Zhang
Publication Year :: 2018
Publisher :: figshare, 2018.
Abstract: Interleukin-6 levels by cytokine release syndrome grade. Peak IL-6 levels by CRS grade. (DOCX 47Â kb)

Full Text Access

Tools